Bile salt sequestration induces the hepatic lipogenic pathway without altering bile salt pool size and transhepatic bile salt flux in mice

2008 ◽  
Vol 154 ◽  
pp. S59
Author(s):  
Hilde Herrema ◽  
Maxi Meissner ◽  
Theo H. van Dijk ◽  
Gemma Brufau-Dones ◽  
Renze Boverhof ◽  
...  
Keyword(s):  
2002 ◽  
Vol 37 (5) ◽  
pp. 556-563 ◽  
Author(s):  
Henk Wolters ◽  
Baukje M Elzinga ◽  
Julius F.W Baller ◽  
Renze Boverhof ◽  
Margrit Schwarz ◽  
...  

2008 ◽  
Vol 294 (2) ◽  
pp. G540-G547 ◽  
Author(s):  
Hester van Meer ◽  
Gunther Boehm ◽  
Frans Stellaard ◽  
Aldwin Vriesema ◽  
Jan Knol ◽  
...  

Human milk contains prebiotic oligosaccharides, which stimulate the growth of intestinal bifidobacteria and lactobacilli. It is unclear whether the prebiotic capacity of human milk contributes to the larger bile salt pool size and the more efficient fat absorption in infants fed human milk compared with formula. We determined the effect of prebiotic oligosaccharides on bile salt metabolism in rats. Rats were fed a control diet or an isocaloric diet containing a mixture of galactooligosaccharides (GOS), long-chain fructooligosaccharides (lcFOS), and acidified oligosaccharides (AOS) for 3 wk. We determined synthesis rate, pool size, and fractional turnover rate (FTR) of the primary bile salt cholate by using stable isotope dilution methodology. We quantified bile flow and biliary bile salt secretion rates through bile cannulation. Prebiotic intervention resulted in significant changes in fecal and colonic flora: the proportion of lactobacilli increased 344% ( P < 0.01) in colon content and 139% ( P < 0.01) in feces compared with the control group. The number of bifidobacteria also increased 366% ( P < 0.01) in colon content and 282% in feces after the prebiotic treatment. Furthermore, pH in both colon and feces decreased significantly with 1.0 and 0.5 pH point, respectively. However, despite this alteration of intestinal bacterial flora, no significant effect on relevant parameters of bile salt metabolism and cholate kinetics was found. The present data in rats do not support the hypothesis that prebiotics naturally present in human milk contribute to a larger bile salt pool size or altered bile salt pool kinetics.


BMJ ◽  
1973 ◽  
Vol 2 (5862) ◽  
pp. 338-340 ◽  
Author(s):  
T. S. Low-Beer ◽  
E. W. Pomare
Keyword(s):  

2012 ◽  
Vol 302 (9) ◽  
pp. G1035-G1042 ◽  
Author(s):  
Frank A. J. A. Bodewes ◽  
Marjan Wouthuyzen-Bakker ◽  
Marcel J. Bijvelds ◽  
Rick Havinga ◽  
Hugo R. de Jonge ◽  
...  

Cystic fibrosis liver disease (CFLD) is treated with ursodeoxycholate (UDCA). Our aim was to evaluate, in cystic fibrosis transmembrane regulator knockout ( Cftr −/−) mice and wild-type controls, whether the supposed therapeutic action of UDCA is mediated via choleretic activity or effects on bile salt metabolism. Cftr −/− mice and controls, under general anesthesia, were intravenously infused with tauroursodeoxycholate (TUDCA) in increasing dosage or were fed either standard or UDCA-enriched chow (0.5% wt/wt) for 3 wk. Bile flow and bile composition were characterized. In chow-fed mice, we analyzed bile salt synthesis and pool size of cholate (CA). In both Cftr −/− and controls intravenous TUDCA stimulated bile flow by ∼250% and dietary UDCA by ∼500%, compared with untreated animals ( P < 0.05). In non-UDCA-treated Cftr −/− mice, the proportion of CA in bile was higher compared with that in controls (61 ± 4 vs. 46 ± 4%; P < 0.05), accompanied by an increased CA synthesis [16 ± 1 vs. 10 ± 2 μmol·h−1·100 g body wt (BW)−1; P < 0.05] and CA pool size (28 ± 3 vs. 19 ± 1 μmol/100 g BW; P < 0.05). In both Cftr −/− and controls, UDCA treatment drastically reduced the proportion of CA in bile below 5% and diminished CA synthesis (2.3 ± 0.3 vs. 2.2 ± 0.4 μmol·day−1·100 g BW−1; nonsignificant) and CA pool size (3.6 ± 0.6 vs. 1.5 ± 0.3 μmol/100 g BW; P < 0.05). Acute TUDCA infusion and chronic UDCA treatment both stimulate bile flow in cystic fibrosis conditions independently from Cftr function. Chronic UDCA treatment reduces the hydrophobicity of the bile salt pool in Cftr −/− mice. These results support a potential beneficial effect of UDCA on bile flow and bile salt metabolism in cystic fibrosis conditions.


1995 ◽  
Vol 269 (6) ◽  
pp. G801-G812 ◽  
Author(s):  
P. J. Meier

An increasingly complex picture has emerged in recent years regarding the bile salt transport polarity of hepatocytes. At the sinusoidal (or basolateral) plasma membrane two bile salt-transporting polypeptides have been cloned. The Na(+)-taurocholate-cotransporting polypeptide (Ntcp) can account for most, if not all, physiological properties of the Na(+)-dependent bile salt uptake function in mammalian hepatocytes. The cloned organic anion-transporting protein (Oatp1) can mediate Na(+)-independent transport of bile salts, sulfobromophthalein, estrogen conjugates, and a variety of other amphipathic cholephilic compounds. Hence, Oatp1 appears to correspond to the previously suggested basolateral multispecific bile sale transporter. Intracellular bile salt transport can be mediated by different pathways. Under basal bile salt flux conditions, conjugated trihydroxy bile salts bind to cytoplasmic binding proteins and reach the canalicular plasma membrane predominantly via cytoplasmic diffusion. More hydrophobic mono- and dihydroxy and high concentrations of trihydroxy bile salts associate with intracellular membrane-bound compartments, including transcytotic vesicles, endoplasmic reticulum (ER), and Golgi complex. A facilitated bile salt diffusion pathway has been demonstrated in the ER. The exact role of these and other (e.g., lysosomes, "tubulovesicular structures") organelles in overall vectorial transport of bile salts across hepatocytes is not yet known. Canalicular bile salt secretion is mediated by two ATP-dependent transport systems, one for monovalent bile salts and the second for divalent sulfated or glucuronidated bile salt conjugates. The latter is identical with the canalicular multispecific organic anion transporter, which also transports other divalent organic anions, such as glutathione S-conjugates. Potential dependent canalicular bile salt secretion has also been suggested to occur, but its exact mechanism and physiological significance remain unclear, since a potential driven bile salt uptake system has also been identified in the ER. Hypothetically, and similar to changes in cell volume, the intracellular potential could also play a role in the regulation of the number of bile salt carriers at the canalicular membrane and thereby indirectly influence the maximal canalicular bile salt transport capacity of hepatocytes.


1980 ◽  
Vol 139 (1) ◽  
pp. 119-124 ◽  
Author(s):  
Joel J. Roslyn ◽  
Lawrence DenBesten ◽  
Jesse E. Thompson ◽  
Kathleen Cohen
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document